Toll-Free Screening, Advice Service Would Enchance OTC Mevacor - Merck
This article was originally published in The Tan Sheet
Executive Summary
Merck would support an OTC version of its statin drug Mevacor with an ambitious customer education program that would ensure proper usage of the cholesterol-lowering medication, the firm stated July 13 at a joint meeting of FDA's Nonprescription and Endocrinologic & Metabolic Drugs Advisory Committees.